Sun, Dec 21, 2014, 4:25 AM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Abbott Laboratories Message Board

  • plutothecat_17 plutothecat_17 Feb 12, 2006 1:18 PM Flag

    Tax Strategies

    Just finished my taxes and owe a bundle because of profits made on ST trades and no ST loss offset.My ABT is all LT CG gains but tax rate is only 15%.Decided one must take losses on ST holdings before they become LT so you can offset to lower ST profit tax.This means keep your eye on NFI ST loss and then make some quick ST profits.I made money on PRZ,BBT,AV,LU,by churning these in < 6 months.The NFI REIT dividend did not help,Now let us try to pick up some quick winners in 2006.Spec-I know I miss the big runup in ELN & KOSP doing this but also avoid the pain of crashes.Your PRZ pick was like an ATM to me do you still hold?

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Bean,
      I'll just start taking my hillbilly /Robi DM!
      Hey, hey SCIENCE of me too!
      O.

    • bean,
      Yes, a lot of people think it is bunk, and it may be, but phase III results have been good. Neurodex is not dextromthorphan by itself, which is broken down by the liver quickly. It is combined with another drug (can't think of it) which makes it longer lasting and more efficient. The FDA will determine the merit, but I have a feeling that it will be approved.
      Phy

    • Bean

      I noticed , and your not the only one.

      Gasp! Kiki

    • i got pluto diseases

      thanks

    • i got pluto diseases

      thanks

    • PRODUCT DESCRIPTION

      Neurodex(TM) (AVP 923) is a patented, orally administered combination of dextromethorphan (DM) and an enzyme inhibitor that sustains elevated levels of dextromethorphan with a once or twice daily dosing schedule. Neurodex is an NMDA receptor antagonist and a sigma-1 agonist. Avanir is in clinical development with Neurodex for use in pseudobulbar affect (PBA) (also known as emotional lability) and neuropathic pain.

      what a joke, dextromethorphan has been used pre-surgery for patients for 30-40 years. all they did was tweek it a bit and increase its auc. bunk....

      thanks

    • PRODUCT DESCRIPTION

      Neurodex(TM) (AVP 923) is a patented, orally administered combination of dextromethorphan (DM) and an enzyme inhibitor that sustains elevated levels of dextromethorphan with a once or twice daily dosing schedule. Neurodex is an NMDA receptor antagonist and a sigma-1 agonist. Avanir is in clinical development with Neurodex for use in pseudobulbar affect (PBA) (also known as emotional lability) and neuropathic pain.

      what a joke, dextromethorphan has been used pre-surgery for patients for 30-40 years. all they did was tweek it a bit and increase its auc. bunk....

      thanks

    • O,
      Neurodex may be approved by the FDA within the next 6 months. It is hoped that it will be approved for neuropathy pain in diabetes. Don't know about other chronic pain.
      Phy

    • Bean,
      In the am fingers not working well use 2 pencils and click like mad.
      Sick n tired of the reg stuff and looking for something new, Thanks for the infirmation if all else fails will get wih Miles and AOK and go offshore!
      O.

    • crepitis, did you say that 3 times because you were high on hillbilly heroin? cramer was pumping some pain therapeutics company (ptie), supossedly they have 2 "non-addictive" opiods in phase III. the stock went up $1.00 the next day, from $7 to $8, now at $9 plus. i have not looked into it that much. see below....

      thanks

      http://www.paintrials.com/

      Pain Therapeutics is providing opiates for the masses. The development-stage company is creating less addictive painkillers by combining an opioid (such as morphine) with an opioid antagonist (such as naloxone), thus improving the drug's performance and decreasing its side effects. Pain Therapeutics has three drugs in clinical trials that could treat everything from severe cancer pain to the chronic pain associated with arthritis. Because the drug candidates contain FDA-approved components, the firm hopes for quicker approval. Founder and CEO Remi Barbier owns nearly a quarter of the company.

    • View More Messages
 
ABT
46.05+0.28(+0.61%)Dec 19 4:01 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Under Armour, Inc.
NYSEFri, Dec 19, 2014 4:04 PM EST
Hecla Mining Co.
NYSEFri, Dec 19, 2014 4:00 PM EST
ImmunoGen, Inc.
NASDAQFri, Dec 19, 2014 4:00 PM EST